News
EMA committee recommends approval of Eli Lilly’s donanemab in early symptomatic Alzheimer's disease: Indianapolis Monday, July 28, 2025, 13:00 Hrs [IST] Eli Lilly and Company an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback